GlassScriptPhysician profile
Kellie Kay Smith
NPI 1982668612
$6,895.40
in general payments reported to CMS, 2019-2025
44 companies · $1,258 in 2025
The $1,258 reported for 2025 was more than what 88% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $911 · 2020: $975 · 2021: $770 · 2022: $884 · 2023: $913 · 2024: $1,185 · 2025: $1,258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,355.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,028.57 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $875.63 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Pfizer INC. | $842.70 | 2019-2025 | |
| Amgen INC. | $537.63 | 2019-2025 | Repatha, Otezla, Evenity |
| Abbvie INC. | $477.40 | 2019-2025 | Ubrelvy, Vraylar |
| Novartis Pharmaceuticals Corporation | $401.08 | 2020-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $376.32 | 2022-2025 | |
| Lilly USA, LLC | $252.08 | 2020-2025 | Mounjaro, Zepbound, Kisunla |
| Amarin Pharma, INC. | $250.11 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $198.01 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Janssen Pharmaceuticals, INC | $194.82 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $138.99 | 2019-2025 | Xifaxan, Trulance |
| Glaxosmithkline, LLC. | $136.23 | 2019-2025 | Trelegy Ellipta |
| Astellas Pharma US INC | $108.08 | 2019-2025 | Veozah |
| Biohaven Pharmaceutical Holding Company LTD. | $82.96 | 2022 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kellie Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.